| Year |
Citation |
Score |
| 2023 |
Tseng JC, Wang BJ, Wang YP, Kuo YY, Chen JK, Hour TC, Kuo LK, Hsiao PJ, Yeh CC, Kao CL, Shih LJ, Chuu CP. Caffeic acid phenethyl ester suppresses EGFR/FAK/Akt signaling, migration, and tumor growth of prostate cancer cells. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 116: 154860. PMID 37201366 DOI: 10.1016/j.phymed.2023.154860 |
0.443 |
|
| 2023 |
Wu HE, Su CC, Wang SC, Liu PL, Cheng WC, Yeh HC, Chuu CP, Chen JK, Bao BY, Lee CH, Ke CC, Chen YR, Yu YH, Huang SP, Li CY. Anticancer Effects of Morusin in Prostate Cancer via Inhibition of Akt/mTOR Signaling Pathway. The American Journal of Chinese Medicine. 1-21. PMID 37120705 DOI: 10.1142/S0192415X23500477 |
0.486 |
|
| 2022 |
Chen YR, Wang SC, Huang SP, Su CC, Liu PL, Cheng WC, Chuu CP, Chen JK, Bao BY, Lee CH, Ke CC, Wu HE, Chang HH, Yeh HC, Li CY. Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 156: 113929. PMID 36411619 DOI: 10.1016/j.biopha.2022.113929 |
0.394 |
|
| 2022 |
Ho CH, Chen ML, Huang HL, Lai CJ, Liu CH, Chuu CP, Lin YH. Active Targeting of P-Selectin by Fucoidan Modulates the Molecular Profiling of Metastasis in Docetaxel-Resistant Prostate Cancer. Marine Drugs. 20. PMID 36135731 DOI: 10.3390/md20090542 |
0.476 |
|
| 2022 |
Wang BJ, Huang SH, Kao CL, Muller CJF, Wang YP, Chang KH, Wen HC, Yeh CC, Shih LJ, Kao YH, Huang SP, Li CY, Chuu CP. Aspalathus linearis suppresses cell survival and proliferation of enzalutamide-resistant prostate cancer cells via inhibition of c-Myc and stability of androgen receptor. Plos One. 17: e0270803. PMID 35776912 DOI: 10.1371/journal.pone.0270803 |
0.481 |
|
| 2022 |
Liu JS, Fang WK, Yang SM, Wu MC, Chen TJ, Chen CM, Lin TY, Liu KL, Wu CM, Chen YC, Chuu CP, Wang LY, Hsieh HP, Kung HJ, Wang WC. Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer. Journal of Biomedical Science. 29: 29. PMID 35534851 DOI: 10.1186/s12929-022-00812-3 |
0.493 |
|
| 2022 |
Yeh HC, Su CC, Wu YH, Lee CH, Bao BY, Cheng WC, Wang SC, Liu PL, Chiu CC, Chuu CP, Ke CC, Wu HE, Chen YR, Chung WJ, Huang SP, et al. Novel insights into the anti-cancer effects of 3-bromopyruvic acid against castration-resistant prostate cancer. European Journal of Pharmacology. 174929. PMID 35364071 DOI: 10.1016/j.ejphar.2022.174929 |
0.512 |
|
| 2022 |
Lin CY, Wang BJ, Fu YK, Huo C, Wang YP, Chen BC, Liu WY, Tseng JC, Jiang SS, Sie ZL, Tsai KK, Yuh CH, Wang WC, Kung HJ, Chuu CP. Inhibition of KDM4C/c-Myc/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolism. Clinical and Translational Medicine. 12: e764. PMID 35343073 DOI: 10.1002/ctm2.764 |
0.441 |
|
| 2022 |
Lai YL, Liu CH, Wang SC, Huang SP, Cho YC, Bao BY, Su CC, Yeh HC, Lee CH, Teng PC, Chuu CP, Chen DN, Li CY, Cheng WC. Identification of a Steroid Hormone-Associated Gene Signature Predicting the Prognosis of Prostate Cancer through an Integrative Bioinformatics Analysis. Cancers. 14. PMID 35326723 DOI: 10.3390/cancers14061565 |
0.354 |
|
| 2022 |
Fu YK, Wang BJ, Tseng JC, Huang SH, Lin CY, Kuo YY, Hour TC, Chuu CP. Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference. Journal of Biomedical Science. 29: 16. PMID 35197069 DOI: 10.1186/s12929-022-00797-z |
0.51 |
|
| 2021 |
Wu MJ, Chen CJ, Lin TY, Liu YY, Tseng LL, Cheng ML, Chuu CP, Tsai HK, Kuo WL, Kung HJ, Wang WC. Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer. Theranostics. 11: 7779-7796. PMID 34335964 DOI: 10.7150/thno.58729 |
0.363 |
|
| 2021 |
Hsu SC, Chen CL, Cheng ML, Chu CY, Changou CA, Yu YL, Yeh SD, Kuo TC, Kuo CC, Chuu CP, Li CF, Wang LH, Chen HW, Yen Y, Ann DK, et al. Arginine starvation elicits chromatin leakage and cGAS-STING activation via epigenetic silencing of metabolic and DNA-repair genes. Theranostics. 11: 7527-7545. PMID 34158865 DOI: 10.7150/thno.54695 |
0.33 |
|
| 2020 |
Shih LJ, Wang JY, Jheng JY, Siao AC, Lin YY, Tsuei YW, Kuo YC, Chuu CP, Kao YH. Betel Nut Arecoline Induces Different Phases of Growth Arrest between Normal and Cancerous Prostate Cells through the Reactive Oxygen Species Pathway. International Journal of Molecular Sciences. 21. PMID 33287214 DOI: 10.3390/ijms21239219 |
0.428 |
|
| 2020 |
Tseng LL, Cheng HH, Yeh TS, Huang SC, Syu YY, Chuu CP, Yuh CH, Kung HJ, Wang WC. Targeting the histone demethylase PHF8-mediated PKCα-Src-PTEN axis in HER2-negative gastric cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 32958674 DOI: 10.1073/Pnas.1919766117 |
0.39 |
|
| 2020 |
Siao AC, Lin YY, Shih LJ, Tsuei YW, Chuu CP, Kuo YC, Kao YH. Endothelin-1 stimulates preadipocyte growth via the PKC, STAT3, AMPK, c-JUN, ERK, sphingosine kinase, and sphingomyelinase pathways. American Journal of Physiology. Cell Physiology. PMID 32755450 DOI: 10.1152/Ajpcell.00491.2019 |
0.321 |
|
| 2020 |
Lin CY, Chuu CP. New classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer. Translational Andrology and Urology. 9: 837-839. PMID 32420195 DOI: 10.21037/Tau.2020.03.24 |
0.491 |
|
| 2020 |
Tseng JC, Huang SH, Lin CY, Wang BJ, Huang SF, Shen YY, Chuu CP. ROR2 suppresses metastasis of prostate cancer via regulation of miR-199a-5p-PIAS3-AKT2 signaling axis. Cell Death & Disease. 11: 376. PMID 32415173 DOI: 10.1038/S41419-020-2587-9 |
0.567 |
|
| 2020 |
Huang SH, Kao YH, Muller CJF, Joubert E, Chuu CP. Aspalathin-rich green Aspalathus linearis extract suppresses migration and invasion of human castration-resistant prostate cancer cells via inhibition of YAP signaling. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 69: 153210. PMID 32217447 DOI: 10.1016/J.Phymed.2020.153210 |
0.554 |
|
| 2019 |
Lin CY, Wang BJ, Chen BC, Tseng JC, Jiang SS, Tsai KK, Shen YY, Yuh CH, Sie ZL, Wang WC, Kung HJ, Chuu CP. Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc. Cancers. 11. PMID 31766290 DOI: 10.3390/cancers11111785 |
0.501 |
|
| 2019 |
Kuo YY, Huo C, Lin CY, Lin HP, Liu JS, Wang WC, Chang CR, Chuu CP. Caffeic acid phenethyl ester suppresses androgen receptor signaling and stability via inhibition of phosphorylation on Ser81 and Ser213. Cell Communication and Signaling : Ccs. 17: 100. PMID 31429764 DOI: 10.1186/S12964-019-0404-9 |
0.547 |
|
| 2019 |
Huang SH, Tseng JC, Lin CY, Kuo YY, Wang BJ, Kao YH, Muller CJF, Joubert E, Chuu CP. Rooibos suppresses proliferation of castration-resistant prostate cancer cells via inhibition of Akt signaling. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 64: 153068. PMID 31419729 DOI: 10.1016/J.Phymed.2019.153068 |
0.578 |
|
| 2019 |
Lai CJ, Lin CY, Liao WY, Hour TC, Wang HD, Chuu CP. CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling. Cells. 8. PMID 30935014 DOI: 10.3390/Cells8040295 |
0.416 |
|
| 2019 |
Yeh CC, Shih LJ, Chang JL, Tsuei YW, Wu CC, Hsiao CW, Chuu CP, Kao YH. Synchronous vascular endothelial growth factor protein profiles in both tissue and serum identify metastasis and poor survival in colorectal cancer. Scientific Reports. 9: 4228. PMID 30862805 DOI: 10.1038/S41598-019-40862-6 |
0.306 |
|
| 2019 |
Chuu C, Lin C, Huang S, Tsai KK-. ACTL6A is a novel oncogene and prognostic biomarker for prostate cancer Annals of Oncology. 30: vi106. DOI: 10.1093/Annonc/Mdz338.069 |
0.585 |
|
| 2018 |
Pai VC, Hsu CC, Chan TS, Liao WY, Chuu CP, Chen WY, Li CR, Lin CY, Huang SP, Chen LT, Tsai KK. Correction: ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling. Oncogene. PMID 30390070 DOI: 10.1038/S41388-018-0561-0 |
0.444 |
|
| 2018 |
Pai VC, Hsu CC, Chan TS, Liao WY, Chuu CP, Chen WY, Li CR, Lin CY, Hwang SP, Chen LT, Tsai KK. ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling. Oncogene. PMID 30266990 DOI: 10.1038/s41388-018-0497-4 |
0.466 |
|
| 2018 |
Lin CY, Jan YJ, Kuo LK, Wang BJ, Huo C, Jiang SS, Chen SC, Kuo YY, Chang CR, Chuu CP. Elevation of Androgen Receptor Promotes Prostate Cancer Metastasis via Induction of EMT and Reduction of KAT5. Cancer Science. PMID 30142696 DOI: 10.1111/Cas.13776 |
0.619 |
|
| 2018 |
Wang HJ, Pochampalli M, Wang LY, Zou JX, Li PS, Hsu SC, Wang BJ, Huang SH, Yang P, Yang JC, Chu CY, Hsieh CL, Sung SY, Li CF, Tepper CG, ... ... Chuu CP, et al. KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC. Oncogene. PMID 30072740 DOI: 10.1038/S41388-018-0414-X |
0.504 |
|
| 2018 |
Chuu C, Lin C, Wang B, Chen B, Tseng J. Histone demethylase KDM4C is a novel oncogene and prognostic biomarker for prostate cancer Annals of Oncology. 29: vii54-vii55. DOI: 10.1093/Annonc/Mdy374.016 |
0.507 |
|
| 2017 |
Chuu CP, Tseng JC, Su LC, Yang SD. Non-Canonical Wnt Receptor ROR2 Suppresses Prostate Cancer Metastasis. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: ix102. PMID 32120488 DOI: 10.1093/Annonc/Mdx621.032 |
0.574 |
|
| 2017 |
Li SM, Chen CH, Chen YW, Yen YC, Fang WT, Tsai FY, Chang JL, Shen YY, Huang SF, Chuu CP, Chang IS, Hsiung CA, Jiang SS. Upregulation of CISD2 augments ROS homeostasis and contributes to tumorigenesis and poor prognosis of lung adenocarcinoma. Scientific Reports. 7: 11893. PMID 28928421 DOI: 10.1038/S41598-017-12131-X |
0.339 |
|
| 2017 |
Lai CJ, Cheng HC, Lin CY, Huang SH, Chen TH, Chung CJ, Chang CH, Wang HD, Chuu CP. Activation of liver X receptor suppresses angiogenesis via induction of ApoD. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 28842423 DOI: 10.1096/Fj.201700374R |
0.352 |
|
| 2017 |
Chen TH, Chen CY, Wen HC, Chang CC, Wang HD, Chuu CP, Chang CH. YAP promotes myogenic differentiation via the MEK5-ERK5 pathway. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 28356344 DOI: 10.1096/Fj.201601090R |
0.341 |
|
| 2016 |
Lin CY, Chuu CP. Friend or foe: role of E-cadherin in prostate cancer metastasis. Translational Andrology and Urology. 5: 961-963. PMID 28078231 DOI: 10.21037/Tau.2016.11.08 |
0.434 |
|
| 2016 |
Tseng JC, Lin CY, Su LC, Fu HH, Yang SD, Chuu CP. CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling. Oncotarget. PMID 27191743 DOI: 10.18632/Oncotarget.9380 |
0.494 |
|
| 2015 |
Lin HP, Lin CY, Huo C, Jan YJ, Tseng JC, Jiang SS, Kuo YY, Chen SC, Wang CT, Chan TM, Liou JY, Wang J, Chang WW, Chang CH, Kung HJ, ... Chuu CP, et al. Akt3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf, & TSC1/TSC2. Oncotarget. PMID 26318033 DOI: 10.18632/Oncotarget.4553 |
0.448 |
|
| 2015 |
Huo C, Kao YH, Chuu CP. Androgen receptor inhibits epithelial-mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells. Cancer Letters. 369: 103-11. PMID 26297988 DOI: 10.1016/J.Canlet.2015.08.001 |
0.505 |
|
| 2015 |
Chang YT, Shu CL, Lai JY, Ching-Yu L, Chuu CP, Morishita K, Ichikawa T, Jessberger R, Fukui Y. SWAP-70 contributes to spontaneous transformation of mouse embryo fibroblasts. Experimental Cell Research. PMID 26103139 DOI: 10.1016/J.Yexcr.2015.06.011 |
0.335 |
|
| 2015 |
Kuo YY, Jim WT, Su LC, Chung CJ, Lin CY, Huo C, Tseng JC, Huang SH, Lai CJ, Chen BC, Wang BJ, Chan TM, Lin HP, Chang WS, Chang CR, ... Chuu CP, et al. Caffeic Acid Phenethyl Ester Is a Potential Therapeutic Agent for Oral Cancer. International Journal of Molecular Sciences. 16: 10748-10766. PMID 25984601 DOI: 10.3390/Ijms160510748 |
0.412 |
|
| 2015 |
Wen HC, Chuu CP, Chen CY, Shiah SG, Kung HJ, King KL, Su LC, Chang SC, Chang CH. Elevation of soluble guanylate cyclase suppresses proliferation and survival of human breast cancer cells. Plos One. 10: e0125518. PMID 25928539 DOI: 10.1371/journal.pone.0125518 |
0.304 |
|
| 2015 |
Lin HP, Lin CY, Huo C, Hsiao PH, Su LC, Jiang SS, Chan TM, Chang CH, Chen LT, Kung HJ, Wang HD, Chuu CP. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1. Oncotarget. 6: 6684-707. PMID 25788262 |
0.457 |
|
| 2015 |
Lin HP, Lin CY, Huo C, Jan YJ, Tseng JC, Jiang SS, Kuo YY, Chen SC, Wang CT, Chan TM, Liou JY, Wang J, Wayne Chang WS, Chang CH, Kung HJ, ... Chuu CP, et al. AKT3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf & TSC1/TSC2 Oncotarget. 6: 27097-27112. DOI: 10.18632/oncotarget.4553 |
0.48 |
|
| 2015 |
Chuu C, Lin C, Tsai KK. Proteomics profiling of epigenetic proteins during acinar morphogenesis to identify prostate cancer prognostic markers Annals of Oncology. 26: vii122. DOI: 10.1093/Annonc/Mdv472.75 |
0.51 |
|
| 2015 |
Huo C, Kao YH, Chuu CP. Androgen receptor inhibits epithelial-mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells Cancer Letters. DOI: 10.1016/j.canlet.2015.08.001 |
0.417 |
|
| 2014 |
Kokontis JM, Lin HP, Jiang SS, Lin CY, Fukuchi J, Hiipakka RA, Chung CJ, Chan TM, Liao S, Chang CH, Chuu CP. Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2. Plos One. 9: e109170. PMID 25271736 DOI: 10.1371/Journal.Pone.0109170 |
0.716 |
|
| 2014 |
Chuang CH, Wang WJ, Li CF, Ko CY, Chou YH, Chuu CP, Cheng TL, Wang JM. The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer. Cell Death & Disease. 5: e1220. PMID 24810056 DOI: 10.1038/cddis.2014.106 |
0.435 |
|
| 2014 |
Kokontis JM, Lin HP, Jiang SS, Lin CY, Fukuchi J, Hiipakka RA, Chung CJ, Chan TM, Liao S, Chang CH, Chuu CP. Correction: Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2 (PLoS ONE (2014) 9, 10 (e109170) DOI: 10.1371/journal.pone.0109170) Plos One. 9. DOI: 10.1371/Journal.Pone.0111731 |
0.714 |
|
| 2013 |
Lin HP, Lin CY, Hsiao PH, Wang HD, Sheng Jiang S, Hsu JM, Jim WT, Chen M, Kung HJ, Chuu CP. Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells. Plos One. 8: e82625. PMID 24349321 DOI: 10.1371/journal.pone.0082625 |
0.488 |
|
| 2013 |
Lin CY, Huo C, Kuo LK, Hiipakka RA, Jones RB, Lin HP, Hung Y, Su LC, Tseng JC, Kuo YY, Wang YL, Fukui Y, Kao YH, Kokontis JM, Yeh CC, ... ... Chuu CP, et al. Cholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cells. Plos One. 8: e65734. PMID 23785446 DOI: 10.1371/journal.pone.0065734 |
0.479 |
|
| 2013 |
Kuo YY, Lin HP, Huo C, Su LC, Yang J, Hsiao PH, Chiang HC, Chung CJ, Wang HD, Chang JY, Chen YW, Chuu CP. Caffeic Acid Phenethyl Ester Suppresses Proliferation and Survival of TW2.6 Human Oral Cancer Cells via Inhibition of Akt Signaling. International Journal of Molecular Sciences. 14: 8801-17. PMID 23615471 DOI: 10.3390/ijms14058801 |
0.304 |
|
| 2013 |
Shu CL, Jing-Yang-Lai, Su LC, Chuu CP, Fukui Y. SWAP-70: a new type of oncogene. Plos One. 8: e59245. PMID 23555004 DOI: 10.1371/Journal.Pone.0059245 |
0.38 |
|
| 2013 |
Lin HP, Lin CY, Liu CC, Su LC, Huo C, Kuo YY, Tseng JC, Hsu JM, Chen CK, Chuu CP. Caffeic Acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signaling. International Journal of Molecular Sciences. 14: 5264-83. PMID 23466879 DOI: 10.3390/Ijms14035264 |
0.593 |
|
| 2013 |
Liu CC, Hsu JM, Kuo LK, Chuu CP. Caffeic acid phenethyl ester as an adjuvant therapy for advanced prostate cancer. Medical Hypotheses. 80: 617-9. PMID 23462369 DOI: 10.1016/J.Mehy.2013.02.003 |
0.586 |
|
| 2013 |
Shu C, Lai J, Su L, Chuu C, Fukui Y. Abstract 3018A: A novel type of oncogene SWAP-70. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-3018A |
0.414 |
|
| 2012 |
Chuu CP, Lin HP, Ciaccio MF, Kokontis JM, Hause RJ, Hiipakka RA, Liao S, Jones RB. Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks. Cancer Prevention Research (Philadelphia, Pa.). 5: 788-97. PMID 22562408 DOI: 10.1158/1940-6207.Capr-12-0004-T |
0.697 |
|
| 2012 |
Lin HP, Jiang SS, Chuu CP. Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells. Plos One. 7: e31286. PMID 22347457 DOI: 10.1371/Journal.Pone.0031286 |
0.579 |
|
| 2012 |
Lin HP, Kuo LK, Chuu CP. Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells. Phytotherapy Research : Ptr. 26: 122-6. PMID 21567511 DOI: 10.1002/Ptr.3523 |
0.392 |
|
| 2012 |
Lin C, Huo C, Lin H, Jiang SS, Chuu C. Abstract 1276: Application of high-throughput proteomics Micro-Western array in studying molecular mechanism of anticancer effect of liver X receptor agonists against human colon cancer cells Cancer Research. 72: 1276-1276. DOI: 10.1158/1538-7445.Am2012-1276 |
0.48 |
|
| 2011 |
Chuu CP, Kokontis JM, Hiipakka RA, Fukuchi J, Lin HP, Lin CY, Huo C, Su LC. Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer. Journal of Biomedical Science. 18: 63. PMID 21859492 DOI: 10.1186/1423-0127-18-63 |
0.622 |
|
| 2011 |
Chuu CP, Kokontis JM, Hiipakka RA, Fukuchi J, Lin HP, Lin CY, Huo C, Huo C, Su LC, Liao S. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc. Cancer Science. 102: 2022-8. PMID 21781227 DOI: 10.1111/J.1349-7006.2011.02043.X |
0.73 |
|
| 2011 |
Chuu CP. Modulation of liver X receptor signaling as a prevention and therapy for colon cancer. Medical Hypotheses. 76: 697-9. PMID 21333456 DOI: 10.1016/J.Mehy.2011.01.037 |
0.534 |
|
| 2011 |
Lin C, Huo C, Lin H, Jiang SS, Chiang C, Chuu C. Abstract C91: Systematically analyzing molecular mechanism of growth inhibition induced by liver × receptor agonists in HT-29 human colon cancer cells using high-throughput micro-Western array and microarray. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-C91 |
0.456 |
|
| 2010 |
Chuu CP, Lin HP. Antiproliferative effect of LXR agonists T0901317 and 22(R)-hydroxycholesterol on multiple human cancer cell lines. Anticancer Research. 30: 3643-8. PMID 20944148 |
0.479 |
|
| 2010 |
Ciaccio MF, Wagner JP, Chuu CP, Lauffenburger DA, Jones RB. Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nature Methods. 7: 148-55. PMID 20101245 DOI: 10.1038/Nmeth.1418 |
0.305 |
|
| 2009 |
Chuu CP, Chen RY, Kokontis JM, Hiipakka RA, Liao S. Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells. Cancer Letters. 275: 86-92. PMID 18977589 DOI: 10.1016/J.Canlet.2008.10.001 |
0.736 |
|
| 2009 |
Liao S, Kokontis JM, Chuu CP, Hiipakka RA. Androgen action and modulation of prostate and prostate cancer growth: An historical perspective Androgen Action in Prostate Cancer. 9-55. DOI: 10.1007/978-0-387-69179-4_1 |
0.475 |
|
| 2008 |
Chuu CP, Chen RY, Barkinge JL, Ciaccio MF, Jones RB. Systems-level analysis of ErbB4 signaling in breast cancer: a laboratory to clinical perspective. Molecular Cancer Research : McR. 6: 885-91. PMID 18567793 DOI: 10.1158/1541-7786.Mcr-07-0369 |
0.4 |
|
| 2007 |
Chuu CP, Chen RY, Hiipakka RA, Kokontis JM, Warner KV, Xiang J, Liao S. The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells. Biochemical and Biophysical Research Communications. 357: 341-6. PMID 17416342 DOI: 10.1016/J.Bbrc.2007.03.116 |
0.715 |
|
| 2007 |
Chuu CP, Kokontis JM, Hiipakka RA, Liao S. Modulation of liver X receptor signaling as novel therapy for prostate cancer. Journal of Biomedical Science. 14: 543-53. PMID 17372849 DOI: 10.1007/S11373-007-9160-8 |
0.743 |
|
| 2006 |
Chuu CP, Hiipakka RA, Kokontis JM, Fukuchi J, Chen RY, Liao S. Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. Cancer Research. 66: 6482-6. PMID 16818617 DOI: 10.1158/0008-5472.Can-06-0632 |
0.725 |
|
| 2005 |
Kokontis JM, Hsu S, Chuu CP, Dang M, Fukuchi J, Hiipakka RA, Liao S. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity. The Prostate. 65: 287-98. PMID 16015608 DOI: 10.1002/Pros.20285 |
0.729 |
|
| 2005 |
Chuu CP, Hiipakka RA, Fukuchi J, Kokontis JM, Liao S. Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice. Cancer Research. 65: 2082-4. PMID 15781616 DOI: 10.1158/0008-5472.Can-04-3992 |
0.715 |
|
| 2004 |
Fukuchi J, Kokontis JM, Hiipakka RA, Chuu CP, Liao S. Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Research. 64: 7686-9. PMID 15520170 DOI: 10.1158/0008-5472.Can-04-2332 |
0.67 |
|
| Show low-probability matches. |